DPYSL2 and acute myeloid leukemia: A total of 163 AML patients from TCGA database showed that AML‐M5 (acute monocytic leukemia) patients had higher DPYSL2 expression than other types of AML (Figure S2A‐B) and patients with high DPYSL2 expression had shorter OS (p = 0.00049) (Figure 2D).